Displaying drugs 14051 - 14075 of 14542 in total
BMS-564929
BMS-564929 is an investigational therapeutic agent built to be a selective androgen receptor modulator (SARM). So far, it has been developed by Bristol-Myers Squibb for the symptomatic treatment of andropause.
Experimental
CCT-018159
Experimental
(S)-famoxadone
Experimental
SD-0006
Investigational
5-(PARA-NITROPHENYL PHOSPHONATE)-PENTANOIC ACID
Experimental
Imiglitazar
Imiglitazar has been used in trials studying the treatment of Diabetes Mellitus.
Investigational
Displaying drugs 14051 - 14075 of 14542 in total